Clinical Practice Study
Copyright ©The Author(s) 2018.
World J Orthop. Mar 18, 2018; 9(3): 41-49
Published online Mar 18, 2018. doi: 10.5312/wjo.v9.i3.41
Table 3 Distribution-based methods for minimum clinically important difference determination of the PROMIS PF CAT, HOOS JR and KOOS JRKOOS JR
InstrumentnSDMDC
1/21/390%95%99%
3-mo from baseline follow-up
PF CAT6633.682.4511.6414.1418.47
HOOS JR995.863.917.5420.8427.22
KOOS JR1296.524.3524.4929.0937.99
> 3-mo from baseline follow-up
PF CAT21334.022.6812.4714.8219.35
HOOS JR2459.336.2228.1133.3943.61
KOOS JR3658.025.3426.2131.1440.67
6-mo from baseline follow-up
PF CAT2643.932.6213.8916.521.55
HOOS JR3110.967.326.3631.3140.89
KOOS JR555.963.9820.8424.7532.33
> 6-mo from baseline follow-up
PF CAT15204.352.913.4615.9820.88
HOOS JR11210.737.1528.8631.941.67
KOOS JR1547.124.7522.9127.2235.55

  • Citation: Hung M, Bounsanga J, Voss MW, Saltzman CL. Establishing minimum clinically important difference values for the Patient-Reported Outcomes Measurement Information System Physical Function, hip disability and osteoarthritis outcome score for joint reconstruction, and knee injury and osteoarthritis outcome score for joint reconstruction in orthopaedics. World J Orthop 2018; 9(3): 41-49
  • URL: https://www.wjgnet.com/2218-5836/full/v9/i3/41.htm
  • DOI: https://dx.doi.org/10.5312/wjo.v9.i3.41